The Global Hypertension Drug Market size was estimated at USD 24.75 billion in 2022, USD 26.88 billion in 2023, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 8.71% to reach USD 48.32 billion by 2030.
The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Hypertension Drug Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.
The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Hypertension Drug Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.
Market Segmentation & Coverage:
This research report categorizes the Global Hypertension Drug Market in order to forecast the revenues and analyze trends in each of following sub-markets:- Based on Therapy, the market is studied across Alpha Blockers, Angiotensin Converting Enzyme Inhibitor, Angiotensin Receptor Blockers, Beta Blockers Vasodilators, Calcium Channel Blockers, Diuretics, and Renin Inhibitors. The Beta Blockers Vasodilators is projected to witness significant market share during forecast period.
- Based on Analysis, the market is studied across Pulmonary Hypertension Drugs and Systemic Hypertension Drugs. The Systemic Hypertension Drugs is projected to witness significant market share during forecast period.
- Based on Type, the market is studied across Combination Therapy and Mono Therapy. The Mono Therapy is projected to witness significant market share during forecast period.
- Based on Distribution, the market is studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy. The Hospital Pharmacy is projected to witness significant market share during forecast period.
- Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.
Market Statistics:
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.FPNV Positioning Matrix:
The FPNV Positioning Matrix is essential for assessing the Global Hypertension Drug Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).Market Share Analysis:
The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Hypertension Drug Market, including AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company, Limited, F. Hoffmann-La Roche Ltd., Gilead Sciences, Inc., GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Lupin Limited, Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A., Sun Pharmaceutical Industries Limited, and Takeda Pharmaceutical Company Limited.The report provides insights on the following pointers:
- Market Penetration: Provides comprehensive information on the market offered by the key players
- Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
- Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
- Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
- Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
- Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
- What is the market size and forecast of the Global Hypertension Drug Market?
- What are the inhibiting factors and impact of COVID-19 shaping the Global Hypertension Drug Market during the forecast period?
- Which are the products/segments/applications/areas to invest in over the forecast period in the Global Hypertension Drug Market?
- What is the competitive strategic window for opportunities in the Global Hypertension Drug Market?
- What are the technology trends and regulatory frameworks in the Global Hypertension Drug Market?
- What is the market share of the leading vendors in the Global Hypertension Drug Market?
- What modes and strategic moves are considered suitable for entering the Global Hypertension Drug Market?
Frequently Asked Questions about the Global Hypertension Drug Market
What is the estimated value of the Global Hypertension Drug Market?
What is the growth rate of the Global Hypertension Drug Market?
What is the forecasted size of the Global Hypertension Drug Market?
Who are the key companies in the Global Hypertension Drug Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 241 |
| Published | May 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 24.75 Billion |
| Forecasted Market Value ( USD | $ 48.32 Billion |
| Compound Annual Growth Rate | 8.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
Table of Contents
1. Preface
2. Research Methodology
4. Market Overview
5. Market Insights
6. Hypertension Drug Market, by Therapy
7. Hypertension Drug Market, by Analysis
8. Hypertension Drug Market, by Type
9. Hypertension Drug Market, by Distribution
10. Americas Hypertension Drug Market
11. Asia-Pacific Hypertension Drug Market
12. Europe, Middle East & Africa Hypertension Drug Market
13. Competitive Landscape
14. Company Usability Profiles
15. Appendix
List of Figures
List of Tables
Companies Mentioned
- AstraZeneca PLC
- Bayer AG
- Boehringer Ingelheim International GmbH
- Daiichi Sankyo Company, Limited
- F. Hoffmann-La Roche Ltd.
- Gilead Sciences, Inc.
- GlaxoSmithKline PLC
- Johnson & Johnson Services, Inc.
- Lupin Limited
- Merck KGaA
- Novartis AG
- Pfizer Inc.
- Sanofi S.A.
- Sun Pharmaceutical Industries Limited
- Takeda Pharmaceutical Company Limited
Methodology
LOADING...
